期刊文献+

月经及性腺功能在成年女性系统性红斑狼疮中的变化 被引量:3

Menstrual and gonadal functional alterations in systemic lupus erythematosus in adult females
下载PDF
导出
摘要 目的探讨月经及性腺功能在成年女性系统性红斑狼疮(SLE)中的变化。方法对先后在本院就诊的SLE患者及在本院进行健康体验的正常对照者进行临床资料收集,详细记录入选研究对象的月经及生育情况,检测研究对象血中性激素水平。结果在入选的192例成年女性SLE患者中,78例(41%)患者出现月经异常,并且患者月经异常的情况表现为多种模式。在100例健康对照者中,仅19例(19%)患者出现月经异常。和健康对照者相比,SLE患者组的性激素E2、P、T明显下降,FSH、LH及PRL的水平均明显升高(P<0.05)。与无月经异常表现的SLE患者相比,有月经异常表现的SLE患者的起病年龄相对较小、SLEDAI积分相对较高、使用过烷化剂的比例相对较高、服用激素的平均剂量相对较大,两组的性腺功能差异无统计学意义(P>0.05)。结论 SLE患者中出现月经异常的比例显著高于健康对照者,有月经异常的SLE患者临床表现具有一定的特点,虽然SLE患者的性腺功能存在异常,但未见其与SLE的月经异常相关。 Objective To investigate menstrual and gonadal functional alterations in systemic lupus erythematosus(SLE) in adult females.Methods The clinical data of 192 consecutive patients who fulfilled four or more of the ACR 1997 revised criteria for SLE(the SLE patients) were studied and compared with 100 age-matched healthy controls,including menstrual function,gonadal function,ad serum Sex Hormone Levels.Results 78(41%) SLE patients and 19(19%) healthy individuals presented menstrual abnormalities.The level of E2,P,T significantly decreased and the level of FSH,LH,PRL significantly increased in SLE patients,compared with that if the healthy controls(P0.05).Younger disease-onset age,higher SLEDAI score,higher use of alkylating agent,and higher dose of glucosteroid therapy were found in patients with menstrual abnormalities than in patients without menstrual abnormalities.Conclusion The incidence of menstrual abnormalities were significantly higher in SLE patients than in healthy controls.SLE patients with menstrual abnormalities were characterized by younger disease-onset age,higher SLEDAI score,higher use of alkylating and higher dose of glucosteroid therapy,but not correlated with gonadal function.
出处 《海南医学》 CAS 2012年第3期9-11,共3页 Hainan Medical Journal
基金 深圳市医学重点学科建设经费资助(编号:2005C10)
关键词 月经 系统性红斑狼疮 性腺功能 Menstrual Systemic lupus erythematosus Gonadal function
  • 相关文献

参考文献11

  • 1Carlson JA, Chen KR. Cutaneous vasculitis update: neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes [J]. Am J Dermatopathol, 2007, 29(1): 32-43.
  • 2Ramos-Casals M, Nardi N, Lagrutta M, et al. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients [J]. Medicine (Baltimore), 2006, 85(2): 95-104.
  • 3Calamia KT, Balabanova M. Vasculitis in systemic lupus erythema- tosis [J]. Clin Dermatot, 2004, 22(2): 148-156.
  • 4代尊昌.环磷酰胺冲击治疗狼疮性肾炎并发狼疮脑的临床疗效[J].海南医学,2005,16(4):112-113. 被引量:3
  • 5Ataya K, Moghissi K. Chemotherapy-induce d premature ovarian failure mechanisms and prevention [J]. Steroids, 1989, 54: 607-626.
  • 6Boumpas DT, Austin HA, Vaughan EM, et al. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamid e therapy [J]. Ann Intern Med, 1993,119: 366-369.
  • 7Chapman RM. Effect of cytotoxic therapy on sexually and gonadal function [J]. Semin Oncol, 1982, 9: 84-94.
  • 8Lim GS, Petri M, Goldman D. Menstruation and systemic lupus ery- thematosus (SLE): a case-control study [J]. Arthritis Rheum, 1993, 36(Suppl 5): 23.
  • 9Rovensky J, Jurankova E, Rauova L, et al. Relationship between en- docrine, immune, and clinical variables in patients with systemic lu- pus erythematosus [J]. J Rheumatol, 1997; 24: 2330-2334.
  • 10Munoz JA, Gil A, Lopez Dupla JM, et al. Sex hormones in chronic systemic lupus erythematous [J]. Ann Med Interne Paris, 1994, 145 (7): 459-463.

二级参考文献4

  • 1Eclwarcls JCW. A donhle blind controlled trial of methyprednisolone infusion in systemic Lupus erythematosus using individualized outcome assessent.Ann Rheum Dis, 1987,46:73.
  • 2Mccune ML. Clinical and immunologic effects of monthly adrnis tration of intravenous cyclophospharnide in severe systemic lupus erythematosus. N Eng Med, 1988,318:1423.
  • 3King J. Cerebral systemic lupus erythematosus. Arch Dis Child, 1988,63.968.
  • 4Steinberg AD, Systemic lupus erythematosus in Wyngorden JB. Cecil texbook of Medicine 18 th Ed,1980,2011.

共引文献2

同被引文献19

  • 1陆再英,钟南山.内科学[M].北京:人民卫生出版社,2008:121.
  • 2Kiyohara C, Washio M, Horiuchi T, et al. Cigarette smoking N-acety ltransferase 2 polymorphisms and systemic lupus erythematosus in a Jap- anese population [ J ]. Lupus, 2009,18 (7) :630-638.
  • 3Boyanov M, Robeva R, Popivanov P. Bone mineral density changes in women with systemic lupus erythematosus [ J ]. Clin Rheumatol,2003,22 (4-5) :318-323.
  • 4Sangle S,D' Cruz DP, Khamashta MA. et al. Antiphospholipid antibod- ies,systemic lupus erythematosus, and non-traumatic metatarsal fractures [J]. Ann Rheum Dis,2004,63(10) :1241-1243.
  • 5Sambrook PN. Steroid-induced osteoporosis [ J ]. Ann Aead Med Singa- pore,2002,31 ( 1 ) :48-53.
  • 6Luigi S, Massimiliano V, Lucia B, et al. Determinants of bone mass in systemic lupus eryth ematosus [ J ] J Rheumatol, 1999,26 ( 6 ) : 1281- 1284.
  • 7Lane NE. An update on glucocorticoid-induced osteoporosis [ J ]. Rheu- matic Diseases Clinics of North America,2001,27( 1 ) :235-253.
  • 8Bischoff-Ferrari HA, Dietrich T, Orar EJ, et al. Positive association be- tween 25-hydroxy vitamin D levels and bone mineral density:a popula- tion-based study of younger and old adults [ J]. Am J Med, 2004,116 (9) :634-639.
  • 9韩智杰,张群群,朱芸,李明.系统性红斑狼疮继发干燥综合征并强直性脊柱炎1例[J].疑难病杂志,2009,8(7):408-408. 被引量:4
  • 10赵露,杨淑珍.六味地黄丸联合激素治疗系统性红斑狼疮疗效观察[J].中国医药,2010,5(1):14-15. 被引量:4

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部